
AI healthcare tools with bias need to be pulled
Health systems need to audit AI algorithms for bias like contaminated medical products, says Avishkar Sharma. Other health leaders have expressed concerns about bias as AI is used more broadly.
Avishkar Sharma, director of artificial intelligence at Jefferson Health and an AI researcher at Stanford University, said he sees a “clinical AI renaissance” in the future.
In a presentation at the HIMSS Global Health Conference & Exhibition, Sharma talked about the potential of AI and the need to closely examine AI tools.
But he also offered words of caution about incorporating AI into clinical practice ethically and safely.
“Be the chief ethical officer of your data,” Sharma said in a presentation at the conference. “Do not wait for a federal mandate to tell you how to audit your algorithm for bias. Establish your own cross functional community today.”
If close scrutiny reveals an AI algorithm is biased, he suggested that it should be treated like a contaminated batch of propofol, a widely used anesthetic.
“You would pull it immediately,” he said. He said the source of the contamination would be investigated, and health systems need to take similar steps if they find bias in their AI tools.
“If an AI system isn't equitable, it is not clinical,” Sharma said. “Ethical AI is not a global checkbox. It is a patient safety obligation.”
Concerns about inequities and racial bias in medicine are well-founded.
The Organ Procurement and Transplantation Network prohibited the use of a biased test of kidney function in determining eligibility for transplants. Researchers found the tests improperly measured kidney function in Black patients, which led to delays in transplants. This week, researchers found
Healthcare leaders have also warned about the potential for AI algorithms and tools such as chatbots to reflect and even expand racial bias.
Dr. Marcus Schabacker, president and CEO of ECRI, told Chief Healthcare Executive® in an interview last month that he’s worried about chatbots amplifying bias in medicine.“If there's bias introduced somewhere in this process, then that bias will be exaggerated the more the chatbot is used,” Schabaker says.
Many medical studies are based largely on participants who are young, white men. If clinicians use chatbots for research for issues affecting women, children, or seniors, and the chatbot is looking at data from a study limited to white men, “then automatically you have a bias,” he says.
“You're going to get a wrong answer,” Schabacker says. “And that bias, depending on how you use it … might be perpetuated through the use and it confirms your own bias.”
Schabacker has also expressed concerns about insufficient governance of AI in large health systems. In 2025, ECRI listed
“We continue to have concerns because, particularly the larger healthcare providers … they don't have a good governance structure to oversee the utilization of AI,” he told Chief Healthcare Executive in a 2025 interview. “And you don't have to stretch your imagination too far to think that if you do not have good governance in place, these new tools can be abused or used in the wrong context.”
Schabacker said in 2025 that if technologies haven’t been thoroughly tested, doctors could use solutions that could provide “a very wrong recommendation.”
“When you tend to rely on those recommendations, they become very quickly decision-making tools, and that's what really concerns us,” he says. “And there's very, very little oversight.”
Researchers with the Stanford School of Medicine tested large language models to see if they were providing biased information. The
The New York City Health Department established a
The New York City health department teamed with The Digital Medicine Society and The SCAN Foundation































































